Epilepsy drug shows promise in slowing joint degeneration in osteoarthritis

Yale researchers have identified a drug target that may alleviate joint degeneration associated with osteoarthritis, a debilitating condition that afflicts as many as 30 million people in the United States alone, which they report in the journal Nature.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup